Brain47Brain47Join Brain47
19P

Phreesia Inc

Healthcare · EUR · F

19P

Price

€7.518

+0.31%

Cap

€617.96M

Earnings

—

30d Trend

-4.7%

19P
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

14% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level15
Momentum64
Technical50
Fund Quality53
Cost Efficiency58

Raw weighted: 60×Macro 0.99 (−1%)=59

RISK

15/100
90d Volatility
13.9%Low
ATR %
0.5%Low daily moves
Max Drawdown (1Y)
-7.8%Resilient

MOMENTUM

64/100
12-1M Momentum
+9.7%Uptrend
6-1M Momentum
+8.8%Positive
1M Return
+0.9%Stable

TECHNICAL

50/100
RSI (14)
57.5Neutral
Price vs SMA200
+5.6%Bullish trend
MACD
0.00Bearish momentum
Bollinger Band
69%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.116Noisy/choppy

FUND QUALITY

53/100
Holdings
10 positionsConcentrated
Domicile
CanadaCheck tax treaty
Yield
4.17% (Monthly)High income

COST EFFICIENCY

58/100
Expense Ratio
0.01%Ultra-low cost
Fund Size (AUM)
$6MMicro (closure risk)

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months34
3-12 months ★64
1-5+ years63

3-6 month opportunity — emerging trend

BRAIN47'S ASSESSMENT

I rate Phreesia Inc at 59/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 85/100. I classify this as a defensive position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+0.9%

3 MONTHS

+1.0%

12 MONTHS

+10.5%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

3-6 month opportunity — emerging trend. low-risk profile and Momentum (64) are the primary strengths. Historical volatility is low at 14%. I classify this as a defensive holding — low volatility and resilient fundamentals provide portfolio ballast.

defensiveScore: 59/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.